Target intelligence / Profile preview

J-domain protein (JDP) (JDP)

Target
JDP
Molecular classification
Molecular chaperone, Cochaperone, DnaJ family
01

Overview

J-domain proteins (JDPs), also known as Hsp40 proteins, are a large and diverse family of molecular cochaperones characterized by a conserved ~70 amino acid J-domain. Their primary function is to regulate the activity of Hsp70 chaperones by stimulating their ATPase activity, which facilitates the capture and folding of client proteins [Kampinga & Craig, 2010, Nature Reviews Molecular Cell Biology]. JDPs play a critical role in protein quality control, preventing the accumulation of misfolded proteins and assisting in the disassembly of protein aggregates [Jiang et al., 2007, Science]. In disease contexts, JDPs are implicated in various cancers where they may promote tumor cell survival, and in neurodegenerative disorders like Parkinson's and Huntington's disease, where their dysfunction contributes to toxic protein aggregation [Mayer & Bukau, 2005, Nature]. Furthermore, certain JDPs are essential for the replication of viruses, such as HIV and Hepatitis C, making them attractive targets for antiviral therapy [Taguwa et al., 2015, Cell Host & Microbe]. Therapeutic strategies targeting JDPs often involve small molecules that disrupt the J-domain's interaction with Hsp70 or inhibit the JDP's ability to stimulate Hsp70, thereby modulating the chaperone network to treat protein-misfolding diseases or cancer [Wisen et al., 2008, ACS Chemical Biology].

Other names
DnaJ proteinHsp40Heat shock protein 40J-proteinCochaperone
02

Mechanism of action

Inhibition of J-domain-mediated stimulation of Hsp70 ATPase activity and disruption of the Hsp70-JDP interaction interface.

03

Biological functions

Protein foldingProtein quality controlHsp70 ATPase stimulationProtein translocationProtein disaggregation
04

Disease associations

CancerNeurodegenerative diseaseInfectionMuscular dystrophyCardiovascular disease
05

Safety considerations

Broad-spectrum inhibition of protein foldingPotential for systemic toxicity due to ubiquitous expressionRisk of inducing protein aggregation in non-target tissues
06

Interacting drugs

Chlorpromazine

3 more in the full profile.

07

Biomarkers

DNAJB1-PRKACA fusion transcriptDNAJB6 expression levelsHsp40 protein levels

Beyond the preview

Go deeper on J-domain protein (JDP) (JDP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on J-domain protein (JDP) (JDP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call